Rowan Digital Works

Effectiveness of a Team-Based Learning exercise in the learning outcomes of a medical pharmacology course: insight from struggling students., Gonzalo A. Carrasco, Kathryn C. Behling, Matthew Gentile, Bradford D. Fischer, Thomas N. Ferraro
Thomas Ferraro

Effectiveness of a Team-Based Learning exercise in the learning outcomes of a medical pharmacology course: insight from struggling students., Gonzalo A. Carrasco, Kathryn C. Behling, Matthew Gentile, Bradford D. Fischer, Thomas N. Ferraro
Bradford Fischer

Effectiveness of a Team-Based Learning exercise in the learning outcomes of a medical pharmacology course: insight from struggling students., Gonzalo A. Carrasco, Kathryn C. Behling, Matthew Gentile, Bradford D. Fischer, Thomas N. Ferraro
Kathryn Behling

Effectiveness of a Team-Based Learning exercise in the learning outcomes of a medical pharmacology course: insight from struggling students., Gonzalo A. Carrasco, Kathryn C. Behling, Matthew Gentile, Bradford D. Fischer, Thomas N. Ferraro
Gonzalo Carrasco

Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis., Toni‐Kim Clarke, Paul J. Bloch, Lisa M. Ambrose‐Lanci, Thomas N. Ferraro, Wade H. Berrettini, Kyle M. Kampman, Charles A. Dackis, Helen M. Pettinati, Charles P. O'Brien, David W. Oslin, Falk W. Lohoff
Thomas Ferraro

Further evidence for association between genetic variants in the cannabinoid receptor 1 (CNR1) gene and cocaine dependence: Confirmation in an independent sample and meta-analysis, Toni-Kim Clarke, Paul J. Bloch, Lisa M. Ambrose-Lanci, Glenn A. Doyle, Thomas N. Ferraro, Wade H. Berrettini, Kyle M. Kampman, Charles A. Dackis, Helen M. Pettinati, Charles P. O’Brien, David W. Oslin, Falk W. Lohoff
Thomas Ferraro

MOR Is Not Enough: Identification of Novel mu-Opioid Receptor Interacting Proteins Using Traditional and Modified Membrane Yeast Two-Hybrid Screens, Jessica Petko, Stephanie Justice-Bitner, Jay Jin, Victoria Wong, Saranya Kittanakom, Thomas N. Ferraro, Igor Stagljar, Robert Levenson
Thomas Ferraro

Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine., Toni-Kim Clarke, Richard C. Crist, Kyle M. Kampman, Charles A. Dackis, Helen M. Pettinati, Charles P. O’Brien, David W. Oslin, Thomas N. Ferraro, Falk W. Lohoff, Wade H. Berrettini
Thomas Ferraro

"…despite many treatment successes in epilepsy overall, the large fraction of patients for whom currently available therapies is inadequate demands that new treatments be developed by targeting molecules different than those involved in the mechanism of action of conventional drugs .", Thomas N. Ferraro
Thomas Ferraro

Discovery of epilepsy susceptibility genes: implications for therapy development and pharmacogenomics., Thomas N. Ferraro
Thomas Ferraro

Association study of the β-arrestin 2 gene (ARRB2) with opioid and cocaine dependence in a European American population, Lisa M. Ambrose-Lanci, Meera Vaswani, Toni Kim Clarke, Angela Zeng, Falk W. Lohoff, Thomas N. Ferraro, Wade H. Berrettini
Thomas Ferraro

Association analysis between polymorphisms in the dopamine D2 receptor (DRD2) and dopamine transporter (DAT1) genes with cocaine dependence, Falk W. Lohoff, Paul J. Bloch, Rachel Hodge, Aleksandra H. Nall, Thomas N. Ferraro, Kyle M. Kampman, Charles A. Dackis, Charles P. O'brien, Helen M. Pettinati, David W. Oslin
Thomas Ferraro

Pharmacogenetic considerations in the treatment of psychiatric disorders, Falk W. Lohoff, Thomas N. Ferraro
Thomas Ferraro

Association analysis between polymorphisms in the conserved dopamine neurotrophic factor (CDNF) gene and cocaine dependence., Falk W. Lohoff, Paul J. Bloch, Thomas N. Ferraro, Wade H. Berrettini, Helen M. Pettinati, Charles A. Dackis, Charles P. O’Brien, Kyle M. Kampman, David W. Oslin
Thomas Ferraro

Genetic variants in the cocaine- and amphetamine-regulated transcript gene (CARTPT) and cocaine dependence, Falk W. Lohoff, Paul J. Bloch, Andrew E. Weller, Aleksandra H. Nall, Glenn A. Doyle, Russell J. Buono, Thomas N. Ferraro, Kyle M. Kampman, Helen M. Pettinati, Charles A. Dackis, David W. Oslin, Charles P. O'Brien, Wade H. Berrettini
Russell Buono

Genetic variants in the cocaine- and amphetamine-regulated transcript gene (CARTPT) and cocaine dependence, Falk W. Lohoff, Paul J. Bloch, Andrew E. Weller, Aleksandra H. Nall, Glenn A. Doyle, Russell J. Buono, Thomas N. Ferraro, Kyle M. Kampman, Helen M. Pettinati, Charles A. Dackis, David W. Oslin, Charles P. O'Brien, Wade H. Berrettini
Thomas Ferraro

Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence., Falk W. Lohoff, Andrew E. Weller, Paul J. Bloch, Aleksandra H. Nall, Thomas N. Ferraro, Kyle M. Kampman, Helen M. Pettinati, David W. Oslin, Charles A. Dackis, Charles P. O'Brien, Wade H. Berrettini
Thomas Ferraro

Challenges and opportunities in the application of pharmacogenetics to antiepileptic drug therapy, Thomas N. Ferraro, Dennis J. Dlugos, Russell J. Buono
Thomas Ferraro

Challenges and opportunities in the application of pharmacogenetics to antiepileptic drug therapy, Thomas N. Ferraro, Dennis J. Dlugos, Russell J. Buono
Russell Buono

Analysis of variations in the tryptophan hydroxylase-2 (TPH2) gene in cocaine dependence, John P. Dahl, Joseph F. Cubells, Riju Ray, Andrew E. Weller, Falk W. Lohoff, Thomas N. Ferraro, David W. Oslin, Kyle M. Kampman, Charles Dackis, Yilang Tang, Joel Gelernter, Henry R. Kranzler, Charles P. O'brien, Wade H. Berrettini
Thomas Ferraro

The relationship between the pharmacology of antiepileptic drugs and human gene variation: an overview., Thomas N. Ferraro, Russell J. Buono
Russell Buono

The relationship between the pharmacology of antiepileptic drugs and human gene variation: an overview., Thomas N. Ferraro, Russell J. Buono
Thomas Ferraro

Lack of association between single nucleotide polymorphisms in the corticotropin releasing hormone receptor 1 (CRHR1) gene and alcohol dependence., John P. Dahl, Glenn A. Doyle, David W. Oslin, Russell J. Buono, Thomas N. Ferraro, Falk W. Lohoff, Wade H. Berrettini
Thomas Ferraro

Lack of association between single nucleotide polymorphisms in the corticotropin releasing hormone receptor 1 (CRHR1) gene and alcohol dependence., John P. Dahl, Glenn A. Doyle, David W. Oslin, Russell J. Buono, Thomas N. Ferraro, Falk W. Lohoff, Wade H. Berrettini
Russell Buono

Pharmacogenetics of Psychotropic Drugs: Genetic influences on responsiveness to anticonvulsant drugs, Thomas N. Ferraro
Thomas Ferraro

Kainate and AMPA receptor binding in seizure-prone and seizure-resistant inbred mouse strains, Veit C. Kürschner, Rebecca L. Petruzzi, Gregory T. Golden, Wade H. Berrettini, Thomas N. Ferraro
Thomas Ferraro

Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse, Wade H. Berrettini, Margret R. Hoehe, Thomas N. Ferraro, Peter A. Demaria, Edward Gottheil
Thomas Ferraro

The effects of repeated morphine exposure on mu opioid receptor number and affinity in C57BL/6J and DBA/2J mice, Rebecca Petruzzi, Thomas N. Ferraro, Veit C. Kürschner, Gregory T. Golden, Wade H. Berrettini
Thomas Ferraro

N-methyl-4-phenylpyridinium (MPP+) potentiates the killing of cultured hepatocytes by catecholamines, Jack W. Snyder, Guillermo M. Alexander, Thomas N. Ferraro, John R. Grothusen, John L. Farber
Thomas Ferraro

In Vivo Microdialysis Study of Brain Ethanol Concentrations in Rats Following Oral Self‐Administration, Thomas N. Ferraro, David P. Carrozza, Wolfgang H. Vogel
Thomas Ferraro